Topics

Sanofi launches type 2 diabetes injectible Suliqua in the UK

05:11 EDT 1 Oct 2019 | SmartBrief

Sanofi's once-daily injection Suliqua, or insulin glargine/lixisenatide, indicated for type 2 diabetes, has been launched in  -More

Original Article: Sanofi launches type 2 diabetes injectible Suliqua in the UK

NEXT ARTICLE

More From BioPortfolio on "Sanofi launches type 2 diabetes injectible Suliqua in the UK"

Quick Search

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...